Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

GENPHARMASEC LTD.

NSE : NABSE : 531592ISIN CODE : INE861N01036Industry : Dyes & PigmentsHouse : Private

BSE1.420.04 (+2.9 %)

PREV CLOSE ( ) 1.38

OPEN PRICE ( ) 1.38

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 396412

TODAY'S LOW / HIGH ( )1.36 1.44

52 WK LOW / HIGH ( ) 1.364.32

NSE

This Company is not listed in NSE

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 16-11 1992

Management Info

- Chairman - Managing Director

Registered Office

Address Office No.104 & 105 (1st Floor),Gundecha Industrial Premises Co-operative Society Ltd,Akurli Road, Kandivali (East),
Mumbai,
Maharashtra-400101

Phone 8655550242

Email info@genpharmasec.com / compliance@genpharmasec.com

Website www.genpharmasec.com

Registrars Details

Satellite Corporate Services Pvt Ltd

Office No A 106 & 107, Dattani Plaza,East West Compound, Andheri Kurla Road,Safedpul, Sakinaka,Mumbai

Listing : BSE

NEWS

24Sep Genpharmasec informs about trading win
Genpharmasec has informed that the Trading Window for dealing in securit..

06Sep Genpharmasec informs about press release
Genpharmasec has informed that the Company has published the Notice of 3..

28Aug Genpharmasec informs about board meeting
Genpharmasec has informed that the meeting of the Board of Directors of..

08Aug Genpharmasec informs about press release
Genpharmasec has informed that it enclosed a copy of extract of the Un-A..

26Jul Genpharmasec acquires 70% stake in Der
Genpharmasec has acquired 70% stake in Derren Healthcare (Target Company..

Financials

Rs. in Millions

	QTR Sep 25	ANNUAL 25
Net Profit	8.14999999999996	24.69
Gross Profit	13.8	34.47
Operating Profit	15.04	38.58
Net Sales	315.64	329.64

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Poddar Pigments (BSE) 253.60 (1.04%)	M.Cap ( in Cr)269.07
Organic Coatings (BSE) 22.02 (3.77%)	M.Cap ( in Cr)21.96
Camex (BSE) 33.00 (1.44%)	M.Cap ( in Cr)33.69
Jaysynth Orgochem (BSE) 15.80 (0.77%)	M.Cap ( in Cr)213.15
Pratiksha Chemicals (BSE) 18.50 (-1.86%)	M.Cap ( in Cr)10.31

Shareholding Pattern

	NON-INSTITUTION	70.02%
	PROMOTERS	29.98%
	MUTUAL FUNDS/UTI	0%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
No Data Found

Risk Disclosures on Derivatives

Smart Quotes

GENPHARMASEC LTD.